370 related articles for article (PubMed ID: 32356572)
1. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
[TBL] [Abstract][Full Text] [Related]
2. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation.
Popovics P; Jain A; Skalitzky KO; Schroeder E; Ruetten H; Cadena M; Uchtmann KS; Vezina CM; Ricke WA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830342
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
Jin R; Forbes CM; Miller NL; Lafin J; Strand DW; Case T; Cates JM; Liu Q; Ramirez-Solano M; Mohler JL; Matusik RJ
Prostate; 2024 Apr; 84(5):441-459. PubMed ID: 38168866
[TBL] [Abstract][Full Text] [Related]
6. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
[TBL] [Abstract][Full Text] [Related]
7. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormone imbalance drives macrophage infiltration and Spp1/osteopontin
Popovics P; Skalitzky KO; Schroeder E; Jain A; Silver SV; Van Fritz F; Uchtmann KS; Vezina CM; Ricke WA
J Pathol; 2023 Jun; 260(2):177-189. PubMed ID: 36825524
[TBL] [Abstract][Full Text] [Related]
9. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
16. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
17. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.
O'Malley KJ; Eisermann K; Pascal LE; Parwani AV; Majima T; Graham L; Hrebinko K; Acquafondata M; Stewart NA; Nelson JB; Yoshimura N; Wang Z
Prostate; 2014 Jun; 74(8):892-900. PubMed ID: 24711254
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.
Bauman TM; Vezina CM; Huang W; Marker PC; Peterson RE; Ricke WA
Am J Clin Exp Urol; 2014; 2(4):313-22. PubMed ID: 25606577
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin expression in prostate cancer and benign prostatic hyperplasia.
Tozawa K; Yamada Y; Kawai N; Okamura T; Ueda K; Kohri K
Urol Int; 1999; 62(3):155-8. PubMed ID: 10529666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
